Verizon Introduces $39 a Month Fios Business Internet Plan for Boston Small Business Owners
Small Business Owners in select Boston zip codes can take advantage of 50 Mbps Verizon…
Month: February 2023
VertexGraph brings Zero Trust Network Access 2.0 (ZTNA 2.0) to remote drive mapping
NEW YORK–(BUSINESS WIRE)–VertexGraph introduces its capability that helps businesses apply Zero Trust Network Access 2.0…
Edifecs Adds Top Sales Talent to Executive Bench
Proven leader to drive Edifecs sales performance, strategy and team BELLEVUE, Wash.–(BUSINESS WIRE)–Edifecs, Inc., a…
ShiftPixy Leverages OpenAI/ChatGPT to Streamline Recruiting and Staffing Opportunity Matching
– Also Elevating Digital Food Ordering and Customer Engagement for Digital Food Brands – MIAMI–(BUSINESS…
KB Home Announces the Grand Opening of Its Newest Community in Highly Desirable St. Augustine
Sabal Estates, located in St. Augustine Shores master-plan, features an abundance of community amenities and…
Market Recovery Hampered by High Housing Costs, Low Supply in January
Pending home sales improved slightly, but an ongoing affordability crisis and lack of homes for…
COMPASS Pathways plc to announce fourth quarter and year-end 2022 financial results on 28 February 2023
Conference call to be held at 8:00am ET (1:00pm UK) LONDON, Feb. 24, 2023 (GLOBE…
Bavarian Nordic to Host Full Year 2022 Results Conference Call
COPENHAGEN, Denmark – February 24, 2023 – Bavarian Nordic A/S (OMX: BAVA) will publish its…
ALTUVIIIO™ approved by the U.S. FDA: this positive event triggers impairment reversal, positively impacting 2022 IFRS net income; no change on business net income (non-IFRS)
FDA approves once-weekly ALTUVIIIO™, a new class of factor VIII therapy for hemophilia A that…
Press release: New Phase 3 data presented at WORLDSymposium™ reinforce Nexviazyme® (avalglucosidase alfa) as potential new standard of care for all people living with late-onset Pompe disease
New Phase 3 data presented at WORLDSymposium™ reinforce Nexviazyme®(avalglucosidase alfa) as potential new standard of…
Black Mountain Investment Group Announces Its Acquisition of Flight GPS, Expanding Its Aviation Portfolio
New York, New York–(Newsfile Corp. – February 24, 2023) – Black Mountain Investment Group (“Black…
BNBTIGER Launches as a Decentralized Community Experiment on Binance Smart Chain to Rebuild Market Trust and Eliminate Zeros
Norfolk, Nebraska–(Newsfile Corp. – February 24, 2023) – BNBTiger has officially launched, marking a new…
Evertz Technologies Limited to Announce Third Quarter 2023 Results on March 2, 2023
Burlington, Ontario–(Newsfile Corp. – February 24, 2023) – Evertz Technologies Limited (TSX: ET) will release…
Cisco and NTT Collaborate to Bring Private 5G to Enterprise Customers to Accelerate Industry Transformation
SAN JOSE, Calif. & LONDON–(BUSINESS WIRE)–Cisco, a worldwide leader in technology, and NTT Ltd., a…
Mind and Body Company Launches Flagship Product Line
Oola’s Mind and Body supplements bring balance and simplicity to your nutrition SALT LAKE CITY–(BUSINESS…
California Resources Corporation Initiates Strategic Realignment of Business Operations and Corporate Structure to Maximize Cash Flow Per Share
Francisco J. Leon to Succeed Mark A. McFarland as President and Chief Executive Officer McFarland…
Life Storage Publishes Investor Presentation Regarding Unsolicited Proposal from Public Storage
Conference Call at 8:00 a.m. Eastern Time Today to Review Presentation, Fourth Quarter and Full…
Castle Biosciences’ Chief Financial Officer Frank Stokes Selected Among the Top 25 CFOs of Houston for 2023 by Finance & Investing
FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #CSTL–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests…
GT Biopharma to Participate in the H.C. Wainwright Cell Therapy Virtual Conference
BRISBANE, CALIFORNIA, Feb. 24, 2023 (GLOBE NEWSWIRE) — GT Biopharma, Inc. (NASDAQ: GTBP), a clinical…
GT Biopharma to Participate in the H.C. Wainwright Cell Therapy Virtual Conference
BRISBANE, CALIFORNIA, Feb. 24, 2023 (GLOBE NEWSWIRE) — GT Biopharma, Inc. (NASDAQ: GTBP), a clinical…